On July 24, Stam Pharmaceuticals (Beijing) Co., Ltd. (hereinafter referred to as “Stam Pharmaceuticals”) and JP Medical Consulting Pty Ltd (hereinafter referred to as “JP Medical Consulting”) of Australia announced a strategic cooperation. The cooperation aims to make full use of the clinical resources and professional advantages of both parties in the field of medicine in China and Australia, promote the internationalization of clinical trials and new drug research and development, and provide Chinese biopharmaceutical companies with one-stop services for clinical trials in Australia.

Read More：